Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | hydroxyprostaglandin dehydrogenase 15-(NAD) | Starlite/ChEMBL | No references |
Escherichia coli | penicillin-binding protein | Starlite/ChEMBL | No references |
Homo sapiens | cytochrome P450, family 2, subfamily C, polypeptide 19 | Starlite/ChEMBL | No references |
Homo sapiens | cytochrome P450, family 1, subfamily A, polypeptide 2 | Starlite/ChEMBL | No references |
Homo sapiens | cytochrome P450, family 2, subfamily D, polypeptide 6 | Starlite/ChEMBL | No references |
Homo sapiens | cytochrome P450, family 2, subfamily C, polypeptide 9 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Brugia malayi | Cytochrome P450 family protein | Get druggable targets OG5_126582 | All targets in OG5_126582 |
Loa Loa (eye worm) | cytochrome P450 family protein | Get druggable targets OG5_126582 | All targets in OG5_126582 |
Mycobacterium tuberculosis | Possible penicillin-binding protein | Get druggable targets OG5_149948 | All targets in OG5_149948 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Leishmania major | cytochrome p450-like protein | cytochrome P450, family 2, subfamily C, polypeptide 19 | 490 aa | 411 aa | 23.1 % |
Brugia malayi | Cytochrome P450 family protein | cytochrome P450, family 1, subfamily A, polypeptide 2 | 516 aa | 470 aa | 26.2 % |
Brugia malayi | cytochrome P450 | cytochrome P450, family 2, subfamily D, polypeptide 6 | 497 aa | 425 aa | 32.0 % |
Plasmodium falciparum | steroid dehydrogenase, putative | hydroxyprostaglandin dehydrogenase 15-(NAD) | 266 aa | 216 aa | 22.2 % |
Mycobacterium tuberculosis | Probable cytochrome P450 136 Cyp136 | cytochrome P450, family 2, subfamily C, polypeptide 9 | 490 aa | 441 aa | 21.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0063 | 0.0611 | 0.1347 |
Trypanosoma cruzi | casein kinase, delta isoform, putative | 0.0153 | 0.4538 | 1 |
Trypanosoma cruzi | casein kinase, putative | 0.0153 | 0.4538 | 1 |
Loa Loa (eye worm) | protein kinase domain-containing protein | 0.0122 | 0.3185 | 0.7018 |
Brugia malayi | Cytochrome P450 family protein | 0.0063 | 0.0611 | 0.1347 |
Echinococcus granulosus | casein kinase I gamma | 0.0122 | 0.3185 | 0.7018 |
Entamoeba histolytica | casein kinase, putative | 0.0153 | 0.4538 | 1 |
Echinococcus multilocularis | casein kinase I alpha | 0.0153 | 0.4538 | 1 |
Trichomonas vaginalis | CK1 family protein kinase | 0.0153 | 0.4538 | 1 |
Echinococcus multilocularis | casein kinase I alpha | 0.0153 | 0.4538 | 1 |
Echinococcus granulosus | casein kinase I alpha | 0.0153 | 0.4538 | 1 |
Trypanosoma cruzi | casein kinase, delta isoform, putative | 0.015 | 0.4411 | 0.9721 |
Trichomonas vaginalis | CK1 family protein kinase | 0.0153 | 0.4538 | 1 |
Loa Loa (eye worm) | casein kinase | 0.0119 | 0.3058 | 0.6738 |
Echinococcus granulosus | casein kinase I delta | 0.0153 | 0.4538 | 1 |
Onchocerca volvulus | 0.0153 | 0.4538 | 1 | |
Plasmodium vivax | casein kinase 1, putative | 0.0153 | 0.4538 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0153 | 0.4538 | 1 |
Brugia malayi | casein kinase I | 0.0153 | 0.4538 | 1 |
Trypanosoma cruzi | casein kinase, putative | 0.0153 | 0.4538 | 1 |
Echinococcus multilocularis | casein kinase I alpha | 0.0153 | 0.4538 | 1 |
Loa Loa (eye worm) | CK1/CK1/CK1-D protein kinase | 0.0153 | 0.4538 | 1 |
Trypanosoma cruzi | casein kinase, putative | 0.0153 | 0.4538 | 1 |
Loa Loa (eye worm) | CK1/CK1/CK1-A protein kinase | 0.0153 | 0.4538 | 1 |
Trypanosoma cruzi | casein kinase, putative | 0.0153 | 0.4538 | 1 |
Echinococcus multilocularis | casein kinase I delta | 0.0153 | 0.4538 | 1 |
Onchocerca volvulus | 0.015 | 0.4411 | 0.9721 | |
Schistosoma mansoni | serine/threonine protein kinase | 0.0122 | 0.3185 | 0.7018 |
Toxoplasma gondii | casein kinase I | 0.0153 | 0.4538 | 1 |
Echinococcus multilocularis | casein kinase I delta | 0.0153 | 0.4538 | 1 |
Echinococcus granulosus | casein kinase I alpha | 0.0153 | 0.4538 | 1 |
Echinococcus granulosus | casein kinase I alpha | 0.0153 | 0.4538 | 1 |
Loa Loa (eye worm) | CK1/CK1/CK1-A protein kinase | 0.0153 | 0.4538 | 1 |
Echinococcus granulosus | casein kinase i | 0.0153 | 0.4538 | 1 |
Leishmania major | casein kinase, putative | 0.0153 | 0.4538 | 1 |
Brugia malayi | casein kinase 1, delta | 0.0153 | 0.4538 | 1 |
Entamoeba histolytica | casein kinase 1, putative | 0.0153 | 0.4538 | 1 |
Brugia malayi | Protein kinase domain containing protein | 0.0122 | 0.3185 | 0.7018 |
Trypanosoma brucei | casein kinase I, isoform 2 | 0.0153 | 0.4538 | 1 |
Giardia lamblia | Kinase, CK1 Casein kinase | 0.0153 | 0.4538 | 1 |
Echinococcus multilocularis | casein kinase I gamma | 0.0122 | 0.3185 | 0.7018 |
Trichomonas vaginalis | CK1 family protein kinase | 0.0153 | 0.4538 | 1 |
Echinococcus multilocularis | casein kinase i | 0.0153 | 0.4538 | 1 |
Schistosoma mansoni | protein kinase | 0.0153 | 0.4538 | 1 |
Plasmodium falciparum | casein kinase 1 | 0.0153 | 0.4538 | 1 |
Echinococcus granulosus | casein kinase I delta | 0.0153 | 0.4538 | 1 |
Trypanosoma cruzi | casein kinase, putative | 0.0153 | 0.4538 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
AC50 (functional) | PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp3a4 Compounds with AC50 equal or less than 10 uM are considered active | ChEMBL. | No reference | |
AC50 (functional) | = 0.398107171 uM | PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2c19 Compounds with AC50 equal or less than 10 uM are considered active | ChEMBL. | No reference |
AC50 (functional) | = 0.446683592 uM | PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2c9 Compounds with AC50 equal or less than 10 uM are considered active | ChEMBL. | No reference |
AC50 (functional) | = 3.16227766 uM | PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp1a2 Compounds with AC50 equal or less than 10 uM are considered active | ChEMBL. | No reference |
AC50 (functional) | = 10 uM | PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2d6 Compounds with AC50 equal or less than 10 uM are considered active | ChEMBL. | No reference |
Potency (functional) | = 7.9433 um | PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))] | ChEMBL. | No reference |
Potency (functional) | 10.4179 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 12.5893 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase). (Class of assay: confirmatory) [Related pubchem assays: 2429 (Confirmation qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2407 (Probe Development Summary for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2427 (Thermal Shift Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase))] | ChEMBL. | No reference |
Potency (binding) | 28.1838 uM | PubChem BioAssay. qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (binding) | = 31.6228 um | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.